Max Shi is a postdoctoral fellow working at AIC, PWH, Chinese University of Hong Kong. Her current research interest focuses on using multi-omics to decipher immune-epithelium interaction in chronic pulmonary disease; establish scalable, ready-to-use disease-conditioned organoids for drug screening and personalised medicine.